Risk factors for fragility fractures in patients with immunobullous diseases on long-term systemic glucocorticoids

Dear Editor, Systemic glucocorticoids remain a cornerstone of therapy in immunobullous diseases. Yet little is known about glucocorticoid induced osteoporosis (GIOP) in patients with immunobullous diseases. We performed a retrospective review of medical records at an immunodermatology clinic in a S...

Full description

Bibliographic Details
Main Authors: MeiQi May Liau, Nisha Suyien Chandran
Format: Article
Language:English
Published: PAGEPress Publications 2024-03-01
Series:Dermatology Reports
Subjects:
Online Access:https://www.pagepress.org/journals/index.php/dr/article/view/9813
_version_ 1797278342828785664
author MeiQi May Liau
Nisha Suyien Chandran
author_facet MeiQi May Liau
Nisha Suyien Chandran
author_sort MeiQi May Liau
collection DOAJ
description Dear Editor, Systemic glucocorticoids remain a cornerstone of therapy in immunobullous diseases. Yet little is known about glucocorticoid induced osteoporosis (GIOP) in patients with immunobullous diseases. We performed a retrospective review of medical records at an immunodermatology clinic in a Singaporean tertiary centre. Inclusion criteria consisted of patients with a newly diagnosed immunobullous condition between January 2011 and October 2017, who were on long-term (>= 3 months) systemic glucocorticoids at a minimum daily dose of prednisolone 15mg. [...]
first_indexed 2024-03-07T16:00:48Z
format Article
id doaj.art-306dc1cdda7a472a8636981dba1ea24f
institution Directory Open Access Journal
issn 2036-7392
2036-7406
language English
last_indexed 2024-03-07T16:00:48Z
publishDate 2024-03-01
publisher PAGEPress Publications
record_format Article
series Dermatology Reports
spelling doaj.art-306dc1cdda7a472a8636981dba1ea24f2024-03-04T19:05:54ZengPAGEPress PublicationsDermatology Reports2036-73922036-74062024-03-0110.4081/dr.2024.9813Risk factors for fragility fractures in patients with immunobullous diseases on long-term systemic glucocorticoidsMeiQi May Liau0Nisha Suyien Chandran1Division of Dermatology, National University of Singapore (NUHS)Division of Dermatology, National University of Singapore (NUHS) Dear Editor, Systemic glucocorticoids remain a cornerstone of therapy in immunobullous diseases. Yet little is known about glucocorticoid induced osteoporosis (GIOP) in patients with immunobullous diseases. We performed a retrospective review of medical records at an immunodermatology clinic in a Singaporean tertiary centre. Inclusion criteria consisted of patients with a newly diagnosed immunobullous condition between January 2011 and October 2017, who were on long-term (>= 3 months) systemic glucocorticoids at a minimum daily dose of prednisolone 15mg. [...] https://www.pagepress.org/journals/index.php/dr/article/view/9813Autoimmune blistering diseasesteroidsfragility fractures
spellingShingle MeiQi May Liau
Nisha Suyien Chandran
Risk factors for fragility fractures in patients with immunobullous diseases on long-term systemic glucocorticoids
Dermatology Reports
Autoimmune blistering disease
steroids
fragility fractures
title Risk factors for fragility fractures in patients with immunobullous diseases on long-term systemic glucocorticoids
title_full Risk factors for fragility fractures in patients with immunobullous diseases on long-term systemic glucocorticoids
title_fullStr Risk factors for fragility fractures in patients with immunobullous diseases on long-term systemic glucocorticoids
title_full_unstemmed Risk factors for fragility fractures in patients with immunobullous diseases on long-term systemic glucocorticoids
title_short Risk factors for fragility fractures in patients with immunobullous diseases on long-term systemic glucocorticoids
title_sort risk factors for fragility fractures in patients with immunobullous diseases on long term systemic glucocorticoids
topic Autoimmune blistering disease
steroids
fragility fractures
url https://www.pagepress.org/journals/index.php/dr/article/view/9813
work_keys_str_mv AT meiqimayliau riskfactorsforfragilityfracturesinpatientswithimmunobullousdiseasesonlongtermsystemicglucocorticoids
AT nishasuyienchandran riskfactorsforfragilityfracturesinpatientswithimmunobullousdiseasesonlongtermsystemicglucocorticoids